MARGARET DYLEWSKI: Open Payments
NPI 1659085124 · WARREN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$370 in 20 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $196 · 2025 $370
Food & beverage: $370
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $61 |
| Verona Pharma, Inc. | 2 | $39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| Amgen Inc. | 2 | $33 |
| PFIZER INC. | 2 | $31 |
| Radius Health, Inc. | 1 | $30 |
| Boston Scientific Corporation | 1 | $25 |
| Abbott Laboratories | 1 | $22 |
| Novo Nordisk Inc | 1 | $21 |
Products named: Ohtuvayre, CAPLYTA, Kerendia, REPATHA, AIRSUPRA, Tymlos, BREZTRI, WATCHMAN FLX.
Industry payments across PA — which companies pay providers there.
